Suppression of plasma viral load below 20 copies/ml is required to achieve a long‐term response to therapy

No abstract is available for this paper.

• Publication year

  1998

• Venue

  AIDS (London)

• Publication date

  1998-09-10

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/00002030-199813000-00008PMID 9764780
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS Trial. Italy, The Netherlands, Canada and Australia Study.

  1998cited by this paper
• The effects of lamivudine treatment on HIV‐1 disease progression are highly correlated with plasma HIV‐1 RNA and CD4 cell count

  1998cited by this paper
• A rapid and simple method for extracting human immunodeficiency virus type 1 RNA from plasma: enhanced sensitivity

  1997cited by this paper
• British HIV Association guidelines for antiretroviral treatment of HIV seropositive individuals. BHIVA Guidelines Co-ordinating Committee.

  1997cited by this paper
• Changes in Plasma HIV RNA Levels and CD4+ Lymphocyte Counts Predict Both Response to Antiretroviral Therapy and Therapeutic Failure

  1997cited by this paper
• Randomised trial of addition of lamivudine or lamivudine plus loviride to zidovudine-containing regimens for patients with HIV-1 infection: the CAESAR trial.

  1997cited by this paper
• Randomised trial of addition of lamivudine or lamivudine plus loviride to zidovudine-containing regimens for patients with HIV-1 infection: the CAESAR trial

  1997cited by this paper
• British HIV Association guidelines for antiretroviral treatment of HIV seropositive individuals.

  1997cited by this paper
• British HIV Association guidelines for antiretroviral treatment of HIV seropositive individuals.

  1997cited by this paper
• Antiretroviral therapy for HIV infection in 1996. Recommendations of an international panel. International AIDS Society-USA.

  1996cited by this paper
• Antiretroviral therapy for HIV infection in 1996 : Recommendations of an international panel

  1996cited by this paper
• Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: application to acute retroviral infection

  1994cited by this paper

• Antiretroviral therapy initiation and its associations with social determinants and clinical outcomes: a retrospective cohort study in Hunan, China

  2025cites this paper
• Accuracy of Provider Predictions of Viral Suppression Among Adolescents and Young Adults With HIV in an HIV Clinical Program

  2024cites this paper
• A Pilot Randomized Control Trial of the Striving Towards EmPowerment and Medication Adherence (STEP-AD) Intervention for Black Women Living with HIV

  2024cites this paper
• Detectable Virological Load and Associated Factors among People Living with HIV on Antiretroviral Treatment: A Retrospective Study

  2024influential citation
• A BAYESIAN DECISION FRAMEWORK FOR OPTIMIZING SEQUENTIAL COMBINATION ANTIRETROVIRAL THERAPY IN PEOPLE WITH HIV.

  2023cites this paper
• Therapeutic drug monitoring of HIV antiretroviral drugs in pregnancy: A narrative review.

  2020cites this paper
• Recruitment of Youth Living With HIV to Optimize Adherence and Virologic Suppression: Testing the Design of Technology-Based Community Health Nursing to Improve Antiretroviral Therapy (ART) Clinical Trials

  2020cites this paper
• Recomendaciones de GESIDA/Plan Nacional sobre el Sida respecto al tratamiento antirretroviral en adultos infectados por el virus de la inmunodeficiencia humana (actualización enero de 2007)

  2019cites this paper
• Changes Over Time in Risk of Initial Virological Failure of Combination Antiretroviral Therapy

  2017cites this paper
• Prevalence and risk factors of poor immune recovery among adult HIV patients attending care and treatment centre in northwestern Tanzania following the use of highly active antiretroviral therapy: a retrospective study

  2017cites this paper
• HIV-Infektion

  2016cites this paper
• HIV-Infektion

  2016cites this paper
• Molecular Detection and Characterization of Human Immunodeficiency Virus Type 1

  2016cites this paper
• Flow-through Capture and in Situ Amplification Can Enable Rapid Detection of a Few Single Molecules of Nucleic Acids from Several Milliliters of Solution.

  2016cites this paper
• Long‐term immune and virological response in HIV‐infected patients receiving antiretroviral therapy

  2016cites this paper
• Improved Performance of COBAS AmpliPrep/COBAS TaqMan Version 2.0 Assay Over Amplicor Monitor Version 1.5 in the Quantification of HIV-1 RNA Viral Load in Abuja, Nigeria.

  2015cites this paper
• Influence of Nevirapine on Gastrointestinal Function

  2015cites this paper
• Recomendations from GESIDA/National AIDS plan on antiretroviral therapy in adult patients infected by the human immunodeficiency virus (October 2004)

  2015cites this paper
• HIV Replication at Low Copy Number and its Correlation with the HIV Reservoir: A Clinical Perspective

  2015cites this paper
• Influence of Long Term Administration of Nevirapine on Serum Liver Enzymes Profile in Albino Wistar Rats

  2015cites this paper
• Rate of and Predicting Factors for Virologic Failure in HIV-Infected Patients with Persistent Low-Level Viremia under Antiretroviral Therapy

  2015cites this paper
• Efavirenz-Based Regimens in Antiretroviral-Naive HIV-Infected Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

  2015cites this paper
• Antiretroviral treatment failure predicts mortality in rural Tanzania

  2015cites this paper
• Development of tuberculosis in human immunodeficiency virus infected patients receiving antiretroviral therapy.

  2014cites this paper
• Nevirapine versus efavirenz for patients co-infected with HIV and tuberculosis: a systematic review and meta-analysis.

  2014cites this paper
• Randomised controlled trial comparing the impact of supplementary feeding with either ready-to-use therapeutic food or corn-soy blend among malnourished anti-retroviral therapy clients in Malawi

  2014cites this paper
• Morphology of the Small Intestine of Albino Wistar Rats Following Long Term Administration of Nevirapine

  2014cites this paper
• Virological failure predicts mortality in HIV-infected patients who receive antiretroviral treatment in rural Tanzania

  2013cites this paper
• Virologic Response to Tipranavir-Ritonavir or Darunavir-Ritonavir Based Regimens in Antiretroviral Therapy Experienced HIV-1 Patients: A Meta-Analysis and Meta-Regression of Randomized Controlled Clinical Trials

  2013cites this paper
• Developing and applying serological and molecular skills to the virological analysis of HIV-infected patients from Kumasi, Ghana

  2013cites this paper
• [Consensus Statement by GeSIDA/National AIDS Plan Secretariat on antiretroviral treatment in adults infected by the human immunodeficiency virus (Updated January 2013)].

  2013cites this paper
• Updates of Lifetime Costs of Care and Quality-of-Life Estimates for HIV-Infected Persons in the United States: Late Versus Early Diagnosis and Entry Into Care

  2013cites this paper
• Nevirapine-Based Regimens in HIV-Infected Antiretroviral-Naive Patients: Systematic Review and Meta-Analysis of Randomized Controlled Trials

  2013cites this paper
• Ulcerogenic and intestinal motility/transit stimulating actions of nevirapine in albino Wistar rats

  2013cites this paper
• Plasma Concentrations of Efavirenz and Nevirapine among HIV-Infected Patients with Immunological Failure Attending a Tertiary Hospital in North-Western Tanzania

  2013cites this paper
• Blips and its clinical relevance in HIV Patients on Treatment

  2012cites this paper
• Initiation of Antiretroviral Therapy : Current Controversies in When and with What to Start

  2012cites this paper
• Combination Therapy of AIDS

  2012cites this paper
• Indinavir

  2012cites this paper
• [Consensus document of Gesida and Spanish Secretariat for the National Plan on AIDS (SPNS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)].

  2012cites this paper
• Cost-Effectiveness of HIV Screening in STD Clinics, Emergency Departments, and Inpatient Units: A Model-Based Analysis

  2011cites this paper
• Molecular Detection and Characterization of HIV-1

  2011cites this paper
• Standardization and performance evaluation of "modified" and "ultrasensitive" versions of the Abbott RealTime HIV-1 assay, adapted to quantify minimal residual viremia.

  2011cites this paper
• Antiretroviral treatment of HIV/AIDS in rural Tanzania: Long-term outcome and simplified monitoring tools

  2011cites this paper
• Correlates between CD 4 reconstitution in HIV patients on suppressive HAART and soluble markers of inflammation and apoptosis

  2010cites this paper
• [AIDS Study Group/Spanish AIDS Plan consensus document on antiretroviral therapy in adults with human immunodeficiency virus infection (updated January 2010)].

  2010cites this paper
• Lack of correlation between three commercial platforms for the evaluation of human immunodeficiency virus type 1 (HIV-1) viral load at the clinically critical lower limit of quantification.

  2010cites this paper
• Molecular Methods for Identification of Cultured Microorganisms

  2010cites this paper
• Triple Combination of Oseltamivir, Amantadine, and Ribavirin Displays Synergistic Activity against Multiple Influenza Virus Strains In Vitro

  2009cites this paper
• Viral Load in Spanish HIV patients: trends since the introduction of HAART.

  2009cites this paper
• Antiretroviral therapy of HIV infection – German-Austrian recommendations

  2009cites this paper
• The effeciveness and determinants of effectiveness of antiretroviral therapy for adults in the Western Cape Province, South Africa

  2009cites this paper
• Effect of Baseline CD4 Cell Counts on the Clinical Significance of Short-Term Immunologic Response to Antiretroviral Therapy in Individuals With Virologic Suppression

  2009cites this paper
• [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].

  2009cites this paper
• Therapeutic drug monitoring of antiretrovirals for people with HIV.

  2009cites this paper
• Antiretrovirale Therapie der HIV-Infektion Deutsch-Österreichische Leitlinien ( Stand September 2008 ) Antiretroviral therapy of HIV infection – German-Austrian recommendations

  2009cites this paper
• Switch from enfuvirtide to raltegravir in virologically suppressed HIV-1 infected patients: effects on level of residual viremia and quality of life.

  2009cites this paper
• Virological efficacy and emergence of drug resistance in adults on antiretroviral treatment in rural Tanzania

  2009cites this paper
• Defining treatment failure in resource-rich settings

  2009cites this paper
• Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel.

  2008cites this paper
• Guidelines for antiretroviral therapy in HIV-1 infected adults and adolescents: the recommendations of the Thai AIDS Society (TAS) 2008.

  2008cites this paper
• The Cost-Effectiveness of Counseling Strategies to Improve Adherence to Highly Active Antiretroviral Therapy among Men Who Have Sex with Men

  2008cites this paper
• Outcomes of nevirapine- and efavirenz-based antiretroviral therapy when coadministered with rifampicin-based antitubercular therapy.

  2008cites this paper
• Cost-Effectiveness of HIV Screening in Patients Older than 55 Years of Age

  2008cites this paper
• [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update January 2007)].

  2007cites this paper
• Evaluation of NucliSens EasyQ HIV-1 assay for quantification of HIV-1 subtypes prevalent in South-east Asia.

  2007cites this paper
• Recommendations of GESIDA/Spanish AIDS Plan on

  2007cites this paper
• Studies on the efficacy and toxicity of highly active antiretroviral therapy

  2007cites this paper
• [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update January 2007)].

  2007cites this paper
• Estudio de la influencia de estímulos inmunológicos repetidos en forma de un calendario vacunal en pacientes adultos infectados por el virus de la inmunodeficiencia humana en estadios tempranos de la infección (con tratamiento antirretroviral y tras su suspensión).

  2007cites this paper
• FOR THE THERAPY OF THE PATIENTS WITH DISSEMINATED MAMMARY CARCINOMA

  2007cites this paper
• Evaluation of HIV-1 viral load and genotypic resistance assays for resource-limited settings

  2007cites this paper
• Human Immunodeficiency Virus Type 1

  2007cites this paper
• CHAPTERR 4 IMPROVEDD LONG-TERM SUPPRESSION OF HIV-1 REPLICATIONN WITH A TRIPLE-CLASS MULTIDRUGG REGIMEN COMPARED TO STANDARDD OF CARE ANTIRETROVIRAL THERAPY Y

  2007cites this paper
• InforMatrix nucleoside/nucleotide reverse transcriptase inhibitor ‘backbones’

  2007cites this paper
• Estudio de carcterísticas fenotípicas del VIH mediante la generación y desarrollo de virus recombinantes: aplicación al estudio de la capacidad replicativa de virus multirresistentes

  2007cites this paper
• Molecular assays for monitoring HIV infection and antiretroviral therapy

  2007cites this paper
• Fully automated quantification of human immunodeficiency virus (HIV) type 1 RNA in human plasma by the COBAS AmpliPrep/COBAS TaqMan system.

  2007cites this paper
• Predictors of disease progression in HIV infection: a review

  2007cites this paper
• Treatment for Adult HIV Infection 2006 Recommendations of the International AIDS Society–USA Panel

  2006cites this paper
• Recommendations of GESIDA/Spanish AIDS Plan on antiretroviral therapy in adults infected by the human immunodeficiency virus (Updated January 2007) Expert Committee of GESIDA and the National AIDS Plan

  2006cites this paper
• Changing antiretroviral therapy in the setting of virologic relapse: Review of the current literature

  2006cites this paper
• [Antiviral treatment regimens].

  2006cites this paper
• Changes over time in risk of initial virological failure of combination antiretroviral therapy: a multicohort analysis, 1996 to 2002.

  2006cites this paper
• Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society--USA panel.

  2006cites this paper
• Molecular Diagnostics for HIV-1

  2006cites this paper
• A comparison between abacavir and efavirenz as the third drug used in combination with a background therapy regimen of 2 nucleoside reverse-transcriptase inhibitors in patients with initially suppressed viral loads.

  2006cites this paper
• HIV-1 Drug Resistance Genotype Results in Patients With Plasma Samples With HIV-1 RNA Levels Less Than 75 Copies/mL

  2006cites this paper
• Disease progression in patients with virological suppression in response to HAART is associated with the degree of immunological response

  2006cites this paper
• Why are Baseline HIV RNA Levels 100,000 Copies/mL or Greater Associated With Mortality After the Initiation of Antiretroviral Therapy?

  2005cites this paper
• Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy.

  2005cites this paper
• Screening for Human Immunodeficiency Virus in Adolescents and Adults

  2005cites this paper
• British HIV Association guidelines for the treatment of HIV‐1‐infected adults with antiretroviral therapy 2008

  2005cites this paper
• AIDS Patients in the Intensive Care Unit

  2005cites this paper
• Immunologic Function and Virologic Suppression Among Children With Perinatally Acquired HIV Infection on Highly Active Antiretroviral Therapy

  2005cites this paper
• Hydroxychloroquine, hydroxyurea and didanosine as initial therapy for HIV‐infected patients with low viral load: safety, efficacy and resistance profile after 144 weeks

  2005cites this paper
• Sequencing antiretroviral drugs for long-lasting suppression of HIV replication.

  2005cites this paper
• HIV Medicine 2005

  2005cites this paper
• HIV testing technologies after two decades of evolution.

  2005cites this paper
• Discordant Immunologic and Virologic Responses to Highly Active Antiretroviral Therapy Are Associated With Increased Mortality and Poor Adherence to Therapy

  2005cites this paper